← All diseases Rare and hereditary disorders

Epidermolysis bullosa

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchMost rigorous evidence only (52)Treatment guideline (7)Meta-analysis (4)Systematic review (18)Phase 3 Study (15)Randomized trial (8)Clinical trial (147)Review article (153)Early study (phase 1 or 2) (20)Single patient description (248)Laboratory or animal research (18)Commentary or editorial (88)Retracted publication (1) Studies currently recruiting participants only (33)

Filter

Publications and studies (1209)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro (2024-07-17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa (2024-04-22) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa (2024-04-09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of Cellutome System for Treatment of Individual Lesions in EB Pts (2024-04-09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs (2024-04-03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa. (2024-03-26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Computational Drug Repurposing for All EBS Cases (2024-02-13) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa (2024-02-13) ♡
• Increased Mortality Risk at Septic Condition in Inflammatory Skin Disorders and the Effect of High-Fat Diet Consumption. (2023/12/29) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Dystrophic epidermolysis with dilation of esophageal stricture: A case report. (2023/12/28) ♡
• MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas. (2023/12/20) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Why are squamous cancers so aggressive in recessive dystrophic epidermolysis bullosa? Can we find new therapeutic approaches? (2023/12/20) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. A short RNA molecule and tumour aggressiveness in people with epidermolysis bullosa. (2023/12/20) ♡
• Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trials. (2023/12/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Biology of Pellino1: a potential therapeutic target for inflammation in diseases and cancers. (2023/12/18) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Crowdfunding to alleviate financial burdens among patients with epidermolysis bullosa. (2023/12/07) ♡
• Monocyte populations are involved in the pathogenesis of experimental epidermolysis bullosa acquisita. (2023/12/05) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Diagnosis, Management, and Outcome of Bart's Syndrome Observed in a Sub-Saharan African Country (Senegal, Dakar): 2 Case Reports. (2023/12/04) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Dupilumab in the treatment of dystrophic epidermolysis bullosa: off-label use in a pediatric patient. (2023/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Exon 8 deletion of KRT5 in epidermolysis bullosa simplex with mottled pigmentation: A case report. (2023/12/01) ♡
• Development of a nutritionally balanced, melt-in-the-mouth chocolate for patients with epidermolysis bullosa. (2023/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Posttranslational modifications of keratins and their associated proteins as therapeutic targets in keratin diseases. (2023/12/01) ♡
• METTL14-mediated N6-methyladenosine modification of Col17a1/Itgα6/Itgβ4 governs epidermal homeostasis. (2023/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case of junctional epidermolysis bullosa intermediate with collagen XVII deficiency treated with dupilumab. (2023/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Epidermolysis bullosa in a mother-infant dyad. (2023/11/28) ♡
• Recessive dystrophic epidermolysis bullosa caused by a novel COL7A1 variant with isodisomy. (2023/11/20) ♡
• Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa. (2023/11/16) ♡
• En Route to Targeted Ribosome Editing to Replenish Skin Anchor Protein LAMB3 in Junctional Epidermolysis Bullosa. (2023/11/10) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Skin Allograft after Bone Marrow Transplantation of Patient with Recessive Dystrophic Epidermolysis Bullosa. (2023/11/09) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case report of jejunum transplantation in the treatment of severe cervical esophageal stricture in patients with dystrophic epidermolysis bullosa. (2023/11/06) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of Human Leukocyte Antigen Class II in Antibody-Mediated Skin Disorders. (2023/11/04) ♡
• Phenotypic variability in LAMA3-associated amelogenesis imperfecta. (2023/11/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Epidermolysis bullosa acquisita induced by atezolizumab. (2023/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Identification of a novel COL7A1 variant associated with dystrophic epidermolysis bullosa pruriginosa responding effectively to dupilumab. (2023/11/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. (New) antenatal ultrasound signs of fetal junctional epidermolysis bullosa: A case report and systematic review of literature. (2023/11/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Painting and dissecting Epidermolysis Bullosa Simplex-associated keratin aggregates. (2023/11/01) ♡
• Challenges in the transfer and scale-up of mini-tableting: Case study with losartan potassium. (2023/11/01) ♡
• Clinical and molecular features in a cohort of Middle Eastern patients with epidermolysis bullosa. (2023/11/01) ♡
• Topical Gene Therapy Restores Vision in Ocular Dystrophic Epidermolysis Bullosa. (2023/11/01) ♡
• [Hereditary epidermolysis bullosa in children]. (2023/11/01) ♡
• [Care of newborns and infants with epidermolysis bullosa]. (2023/11/01) ♡
• [EB care by a home care nurse: mission impossible?]. (2023/11/01) ♡
• [Growing up with an EBH, an example of pediatric-adult transition in the field of rare diseases]. (2023/11/01) ♡
• [Cutaneous squamous cell carcinomas in EBDR: how can they be detected?]. (2023/11/01) ♡
• [Cutaneous squamous cell carcinomas: a complication of severe forms of hereditary epidermolysis bullosa]. (2023/11/01) ♡
• [Adapting technical care to EBH patients]. (2023/11/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. [Epidermolysis bullosa acquisita triggered by Atezolizumab]. (2023/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Missense Variant c.3301C>T (p.R1101W) in von Willebrand Factor A Sequence in a Patient with Recessive Dystrophic Epidermolysis Bullosa Pruriginosa with Compound Heterozygous COL7A1 Variants. (2023/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Integrin α3 mutation junctional epidermolysis bullosa presenting with hypotrichosis and lacrimal obstruction. (2023/10/30) ♡
• Epidermolysis Bullosa Acquisita. (2023/10/29) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.